How does the immune landscape of NEPC differ from primary/met prostate adenocarcinomas & SCLC? We explore these questions in our recent work collab ⁦@mishabeltran⁩ ⁦@ElementoLab⁩ ⁦@WCMEnglanderIPM⁩ & published in ⁦@AACR⁩ ⁦⁩.

RT @WSJ: CDC says the coronavirus pandemic could be under control in four to eight weeks if everyone wore a mask starting now https://t.co/….

RT @VanAllenLab: Interested to see how the forthcoming data behind the ‘TMB > 10 in all cancer types’ approval addresses a few key issues,….